Murdoch R

References (1)

Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW
Ref : Lancet Neurol , 7 :779 , 2008
Abstract :
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779
PubMedID: 18672400